Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
2011 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Value of complete metabolic response by 18F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy
2007
Guidelines for the welfare and use of animals in cancer research
2010 Standout
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Gastric cancer
2016 Standout
Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging
2005 StandoutNobel
Molecular imaging in drug development
2008 Standout
Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus
2012 Standout
Pancreatic cancer
2004 Standout
American College of Gastroenterology Guideline: Management of Acute Pancreatitis
2013 Standout
Assessment of tumor response in malignant pleural mesothelioma
2007
Adjuvant and Neoadjuvant Therapy for Gastric Cancer
2005
Monitoring chemotherapy and radiotherapy of solid tumors
2006
Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer
2002
[18F]FDG PET monitoring of tumour response to chemotherapy: does [18F]FDG uptake correlate with the viable tumour cell fraction?
2003
Carcinoma of the gallbladder
2003
Predictive Value of 18-Fluoro-Deoxy-Glucose-Positron Emission Tomography (18F-FDG-PET) in the Identification of Responders to Chemoradiation Therapy for the Treatment of Locally Advanced Esophageal Cancer
2006
Imaging in the era of molecular oncology
2008 StandoutNature
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer1
2004
Early Prediction of Response to Chemotherapy and Survival in Malignant Pleural Mesothelioma Using a Novel Semiautomated 3-Dimensional Volume-Based Analysis of Serial 18F-FDG PET Scans
2007
Using imaging biomarkers to accelerate drug development and clinical trials
2005
Pancreatic cancer
2016 Standout
Esophageal Cancer
2003 Standout
Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: A meta-analysis
2009
Use of new imaging techniques to predict tumour response to therapy
2010
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
2019 Standout
Photodynamic therapy for cancer
2003 Standout
FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: A meta-analysis
2013
Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: A meta-analysis
2014
3D Slicer as an image computing platform for the Quantitative Imaging Network
2012 Standout
Assessing responses to cancer therapy using molecular imaging
2006
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Trends in the Utilization of Endoscopic Retrograde Cholangiopancreatography (ERCP) in the United States
2007
Perspectives in the treatment of gastric cancer
2005
Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis
2004
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer
2002
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer
2011
NCCN Task Force: Clinical Utility of PET in a Variety of Tumor Types
2009
Detection and chemoradiotherapeutic evaluation of advanced esophageal squamous cell carcinoma using gallium-67 SPET: a preliminary study
2002
Oesophageal carcinoma
2013 Standout
A survey on deep learning in medical image analysis
2017 Standout
A prospective evaluation of the utility of 2‐deoxy‐2‐[18F]fluoro‐D ‐glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer
2012
Clinical molecular imaging with positron emission tomography
2006
New approaches for imaging tumour responses to treatment
2008
Diagnosis of pancreatic cancer
2006
Meta‐analysis: the detection of pancreatic malignancy with positron emission tomography
2004
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
EUS vs MRCP for detection of choledocholithiasis
2006
Comparison of Endoscopic Ultrasonography and Magnetic Resonance Cholangiopancreatography in the Diagnosis of Pancreatobiliary Diseases: A Prospective Study
2007
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Solid Cancer Incidence in Atomic Bomb Survivors: 1958–1998
2007 Standout
2‐Fluoro‐2‐deoxy‐D‐glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma
2004
Positron emission tomography in hepatobiliary and pancreatic malignancies: a review
2012
Photodynamic therapy of cancer: An update
2011 Standout
Gastric cancer
2020 Standout
Neoadjuvant chemotherapy for advanced gastric cancer: A meta-analysis
2010
Pancreatic Cancer
2010 Standout
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer
2006
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
2007
Predicting Response to Neoadjuvant Chemotherapy with PET Imaging Using Convolutional Neural Networks
2015
Practice Guidelines in Acute Pancreatitis
2006 Standout
Photodynamic therapy of nonresectable cholangiocarcinoma
1998
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer
2004
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Pancreatic cancer
2011 Standout
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach
2004
Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
2008
Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer
2005
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
2011 Standout
Whole Body 18FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial
2003
Use of PET for monitoring cancer therapy and for predicting outcome.
2005
Adverse events associated with ERCP
2016 Standout
Revised Response Criteria for Malignant Lymphoma
2007 Standout
Positron Emission Tomography As an Imaging Biomarker
2006
The added value of metabolic imaging with FDG-PET in oesophageal cancer: prognostic role and prediction of response to treatment
2006
Combined GADD45A and Thymidine Phosphorylase Expression Levels Predict Response and Survival of Neoadjuvant-Treated Gastric Cancer Patients
2005
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
2010
Magnetic Resonance Cholangiopancreatography
2003
Positron-Emission Tomography and Assessment of Cancer Therapy
2006
[18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of Tumors
2005
Predicting Difficult Intubation in Apparently Normal Patients
2005 Standout
Prediction of Response to Preoperative Chemotherapy in Gastric Carcinoma by Metabolic Imaging: Results of a Prospective Trial
2003
Positron Emission Tomography Is Superior to Computed Tomography Scanning for Response-Assessment After Radical Radiotherapy or Chemoradiotherapy in Patients With Non–Small-Cell Lung Cancer
2003
Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
2006
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
The revised Atlanta classification for acute pancreatitis: updates in imaging terminology and guidelines
2012
Early Metabolic Response Evaluation by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Allows In vivo Testing of Chemosensitivity in Gastric Cancer: Long-term Results of a Prospective Study
2008
A systematic review and economic evaluation of magnetic resonance cholangiopancreatography compared with diagnostic endoscopic retrograde cholangiopancreatography
2004
Works of H. Helmberger being referenced
Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study
2003
Adenocarcinoma of the gastro-esophageal junction: CT for monitoring during neoadjuvant chemotherapy
1996
A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures
2002
Radiologic Diagnosis and Staging of Gallbladder and Bile Duct Tumors
1993
CT for local staging of esophageal cancer
1999
Dynamic MR Pancreatography After Secretin Administration: Image Quality and Diagnostic Accuracy
2002
Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging
2001
Preoperative Evaluation of Pancreatic Masses with Positron Emission Tomography Using 18F‐fluorodeoxyglucose: Diagnostic Limitations
2000